Predictive Modeling for Cohorts of Patients with Melanoma
Study on the Efficacy of an Investigational Medication for Hypertension
Not Recruiting
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Melanoma
Age:
18 years - 100 years
Gender: All
Who can participate: Adults aged 18 to 65 with a diagnosis of hypertension and no history of severe cardiovascular events are eligible to participate.
Study details: Participants will receive the investigational medication and attend regular clinic visits for blood pressure monitoring and health evaluations.
Updated on
19 Feb 2024.
Study ID: 0710-68
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
